Australian x-ray developer Micro-X is collaborating with the University of Sydney on a proof-of-concept miniaturized stationary CT for lung cancer screening, with Micro-X set to receive $1.3 million under the agreement.
University of Sydney will lead an 18-month research program evaluating the feasibility of the device for lung imaging applications, according to the company. The objective is to establish a laboratory-based test bench for detecting lung cancer, the company noted. The test bench will incorporate multiple Micro-X Nano Electronic X-ray (NEX) tubes and will be used to evaluate imaging geometry, photon measurement techniques, and system integration concepts. It will not be a medical device intended for clinical use, according to the company.
The project continues work from Stage 1 of the Australian Government's Critical Technologies Challenge Program, which provided the project's $1.9 million in total funding. Micro-X's share covers providing an existing imaging chain, technical support, and services, the company said.
